High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.8M
$2,766,203
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shields Matthew
• Officer • EVP, Global Operations
10b5-1 SellΔOwn -63.4%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Global Operations
10b5-1 SellΔOwn -63.4%
|
2026-03-05 | $547,705 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Savage Brian
• Officer • Interim Chief Legal Officer
Sell to Cover
2026-03-05
$35,690
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Interim Chief Legal Officer
Sell to Cover
|
2026-03-05 | $35,690 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Jover Placid
• Officer • See "Remarks"
10b5-1 SellΔOwn -67.6%
2026-03-05
$448,108
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
10b5-1 SellΔOwn -67.6%
|
2026-03-05 | $448,108 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Hughes Eric A
• Officer • See "Remarks"
Sell to Cover
2026-03-05
$301,895
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Sell to Cover
|
2026-03-05 | $301,895 | S | Form 4 |
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CEO
Sell to Cover
|
2026-03-05 | $634,160 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Fox Christine
• Officer • EVP, U.S. Commercial
Sell to Cover
2026-03-05
$250,940
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, U.S. Commercial
Sell to Cover
|
2026-03-05 | $250,940 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
|
2026-03-05 | $547,705 | S | Form 4 |